PTPRC and neoplasm: We verified that neutrophil depletion with the anti-Ly6G antibody technically worked in both models, evident by the reduced frequency of CD45+CD11b+Ly6G+ cells in blood, spleen and tumor samples collected at day 9 and day 12 (CM and YUMMER1.7 models, respectively; Extended Data Fig. 3c).